Transgenomic (TBIO) Tops Q1 EPS by 1c

May 11, 2023 4:22 PM EDT

Transgenomic (NASDAQ: TBIO) reported Q1 EPS of ($0.37), $0.01 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $6.31 million versus the consensus estimate of $6.8 million.

For earnings history and earnings-related data on Transgenomic (TBIO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings